You are here:

Lansoprazole oro-dispersible tablet (Zoton FasTab®)


Following an abbreviated submission

Lansoprazole oro-dispersible tablet (Zoton FasTab) is accepted for use in NHS Scotland, in combination with appropriate antibiotics, for the eradication of Helicobacter pylori from the upper gastrointestinal tract in patients with ulcer-like dyspepsia in whom Helicobacter pylori infection has been demonstrated.

The standard formulation of lansoprazole also has this indication.

Drug Details

Drug Name: Lansoprazole oro-dispersible tablet (Zoton FasTab®)
SMC Drug ID: 229/05
Manufacturer: Wyeth Pharmaceuticals
Indication: Eradication of Helicobacter pylori
BNF Category:
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 9 January 2006